New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
10:25 EDTDRRX, DRRX, PCRX, PCRXSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Durect's (DRRX) Posidur for post-operative pain, its safety and whether it could be disruptive to Pacira Pharmaceuticals (PCRX) on an Analyst/Industry conference call to be held on January 8 at 11 am.
News For DRRX;PCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2016
15:28 EDTPCRXFollow-up: Pacira upgraded to Buy on valuation at BofA/Merrill
Subscribe for More Information
15:13 EDTPCRXPacira upgraded to Buy from Neutral at BofA/Merrill
Subscribe for More Information
January 27, 2016
07:30 EDTPCRXPiper reiterates Overweight on Pacira after surgeon survey
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use